Pfizer And BioNTech Ask FDA To Authorize Omicron Covid Booster

On Monday, Pfizer and BioNTech announced they have asked the FDA to grant an emergency use authorization for their new version of a Covid-19 vaccine that’s been adapted to be specific to the BA.4/BA.5 versions of the Omicron variant.